• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Susannah Fox

I help people navigate health and technology.

  • Home
  • Rebel Health
  • Blog
    • greatest hits
    • health data
    • peer-to-peer health care
    • public Q&A
  • About me
    • Bio
    • Now
    • Curriculum vitae
  • Events

Big (really big) data comes to health care

March 4, 2014 By Susannah Fox Leave a Comment

In December 2013, Kira Peikoff wrote about how, when she had her DNA tested by three direct-to-consumer companies, the results were all over the place. She interviewed experts to get their advice:

J. Craig Venter, chief executive of his namesake institute and of Synthetic Genomics, was a pioneer in sequencing the human genome in 2000. Though he issued recommendations to genetic testing companies four years ago to help them improve their predictions, he remains skeptical of their clinical value.

“Your results are not the least bit surprising,” he told me. “Anything short of sequencing is going to be short on accuracy — and even then, there’s almost no comprehensive data sets to compare to.”

Now, it seems, Venter is setting out to solve this issue:

Venter says he’ll soon begin sequencing up to 40,000 genomes a year, and quickly ramp up to 100,000, to find the mutations that contribute to age-related illnesses such as heart disease and cancer, which collectively kill about 1.2 million people a year in the U.S.

[…]

Cancer is the company’s first target. HLI also will tackle increasingly common afflictions such as Alzheimer’s and Parkinson’s disease. The diseases are a large and growing focus of local scientists, including those at UC San Diego, which last year created an Institute for Genomic Medicine.

And they’re not just after genotypes. HLI (Human Longevity, Inc.) is collecting microbiome and phenotype data, too. That is some seriously big data.

Is this a new level of information haves and have-nots? Are we going to be separated into two groups: those who can get their whole genome sequenced vs. those who cannot? Is it even worth doing the consumer-strength genetic testing? I’ll give the final word to Arthur Caplan, director of medical ethics at the New York University Langone Medical Center:

The tests “may be interesting as a kind of entertainment,” Dr. Caplan said, “but do not take them seriously yet in driving your health care or your lifestyle.”

He added: “If you want to spend money wisely to protect your health and you have a few hundred dollars, buy a scale, stand on it, and act accordingly.”

(If you want to learn more about Human Longevity, Inc., here’s today’s press release.)

Filed Under: key people Tagged With: big data, genomics, Quantified Self, Tracking for Health

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Explore

Don't miss a post

Enter your email address and receive notifications of new posts by email.

Topics

  • Seekers
  • Networkers
  • Solvers
  • Champions
  • Health Data
  • Peer-to-Peer Health Care
  • Public Q&A

Recent Comments

  • Susannah Fox on Public Q&A: “I received scary test results. What questions should I ask my clinician?”: “Thanks, Samantha! I love your signature line/bona fides list — you tick the boxes for “learned and loved experience” described…” May 6, 15:33
  • Samantha Bridge on Public Q&A: “I received scary test results. What questions should I ask my clinician?”: “Great conversation. It has been my experience as a nurse to have the conversation before the testing. What is the…” May 4, 09:05
  • Susannah Fox on Rare Disease in the NYT: “Captivated is such a good description of how I felt, too. I read the essay once through quickly, then a…” Apr 25, 11:12

Copyright Susannah Fox © 2025 · WordPress · Log in